Does NIVOLUMAB Cause Hepatic function abnormal? 1,131 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,131 reports of Hepatic function abnormal have been filed in association with NIVOLUMAB (OPDIVO). This represents 1.3% of all adverse event reports for NIVOLUMAB.
1,131
Reports of Hepatic function abnormal with NIVOLUMAB
1.3%
of all NIVOLUMAB reports
283
Deaths
636
Hospitalizations
How Dangerous Is Hepatic function abnormal From NIVOLUMAB?
Of the 1,131 reports, 283 (25.0%) resulted in death, 636 (56.2%) required hospitalization, and 115 (10.2%) were considered life-threatening.
Is Hepatic function abnormal Listed in the Official Label?
Yes, Hepatic function abnormal is listed as a known adverse reaction in the official FDA drug label for NIVOLUMAB.
What Other Side Effects Does NIVOLUMAB Cause?
Death (11,216)
Malignant neoplasm progression (9,363)
Off label use (5,208)
Diarrhoea (4,692)
Fatigue (3,709)
Pyrexia (3,454)
Intentional product use issue (3,297)
Rash (2,816)
Nausea (2,805)
Decreased appetite (2,619)
What Other Drugs Cause Hepatic function abnormal?
PEMBROLIZUMAB (1,079)
METHOTREXATE (1,054)
CABOZANTINIB S-MALATE (912)
CYCLOPHOSPHAMIDE (824)
BEVACIZUMAB (769)
PACLITAXEL (603)
LENVATINIB (528)
ATORVASTATIN (520)
CYCLOSPORINE (508)
CARBOPLATIN (498)
Which NIVOLUMAB Alternatives Have Lower Hepatic function abnormal Risk?
NIVOLUMAB vs NIVOLUMAB\RELATLIMAB-RMBW
NIVOLUMAB vs NIZATIDINE
NIVOLUMAB vs NOMEGESTROL
NIVOLUMAB vs NORDAZEPAM
NIVOLUMAB vs NOREPINEPHRINE